|
|
|
Volumn 9, Issue 4, 1996, Pages 315-328
|
|
Ancrod: Clinical indications and methods of use
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANCROD;
ANTISERUM;
DEXTRAN;
HEPARIN;
HIRUDIN DERIVATIVE;
MANNITOL;
STREPTOKINASE;
THROMBIN INHIBITOR;
TISSUE PLASMINOGEN ACTIVATOR;
UROKINASE;
ANIMAL EXPERIMENT;
ATHEROSCLEROSIS;
BLOOD CLOT LYSIS;
BLOOD VESSEL GRAFT;
DOSE RESPONSE;
DRUG MECHANISM;
GLOMERULONEPHRITIS;
HUMAN;
INTERMITTENT CLAUDICATION;
INTRAVENOUS DRUG ADMINISTRATION;
LEG ISCHEMIA;
LUNG EMBOLISM;
NONHUMAN;
PERIPHERAL VASCULAR DISEASE;
PRIORITY JOURNAL;
RAT;
REVIEW;
STROKE;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTE AGGREGATION;
THROMBOCYTOPENIA;
THROMBOSIS;
ANCROD;
ANIMALS;
ANTICOAGULANTS;
BLOOD COAGULATION;
BLOOD VISCOSITY;
FIBRINOLYSIS;
GLOMERULONEPHRITIS;
HUMANS;
INTERMITTENT CLAUDICATION;
ISCHEMIA;
LEG;
PULMONARY EMBOLISM;
RANDOMIZED CONTROLLED TRIALS;
REGIONAL BLOOD FLOW;
STREPTOKINASE;
THROMBOLYTIC THERAPY;
THROMBOSIS;
URINARY PLASMINOGEN ACTIVATOR;
|
|
EID: 0029839605
PISSN: 08957967
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
